Impact of non ‐adherence on the safety and efficacy of uric acid‐lowering therapies in the treatment of gout

ConclusionsSuboptimal medication adherence may compromise the safety and efficacy of mono‐ and dual‐ULTs, especially in patients with gout resulting from an overproduction of uric acid. Clinicians and pharmacists should consider counselling patients with respect to the risks associated with partial adherence, and offer interventions to improve adherence or tailor treatments, where appropriate.
Source: British Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Tags: THERAPEUTICS Source Type: research